Tff Pharmaceuticals Inc (TFFP) Financials

$0.07

$0.00 (0.00%)

As on 26-Feb-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	1.78	0.73	--	0.00	--	--
Cost of Revenue	0.41	0.50	0.39	0.11	--	--
Gross Profit	1.37	0.23	-0.39	-0.11	--	--
Operating Expenses	19.59	22.13	31.80	31.79	18.69	11.99
Operating Profit (EBIT)	-19.02	-21.89	-31.80	-31.79	-18.69	-11.99
Other Income	--	--	--	0.70	--	--
Profit before Tax	-18.52	-21.24	-31.77	-31.04	-18.57	-11.87
Provision for Tax	0.00	--	0.00	-0.05	-0.13	-0.12
Profit after Tax (Net Income)	-18.52	-21.24	-31.77	-30.99	-18.44	-11.75
Minority Interest	--	--	--	31.04	--	--
Consolidated Profit	--	--	--	-31.04	-18.57	-36.68

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	3.14	9.57	22.88	38.74	37.34	27.64
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.03	0.11	0.42	1.32	1.13
Current Liabilities	3.94	2.43	1.13	1.96	1.32	0.41
Total Liabilities	11.02	12.03	24.12	40.70	38.66	29.19

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	3.57	4.44	5.10	1.86	1.10	--
Current Assets	3.51	7.59	19.03	38.84	37.56	29.19
Total Assets	11.02	12.03	24.12	40.70	38.66	29.19
Total Debt*	0.05	0.12	0.19	--	--	--
Net Current Assets	-0.43	5.16	17.89	36.88	36.24	28.78

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-16.04	-27.34	-29.56	-16.62	-11.22
Cash Flow from Investing Activities	--	--	--	-0.87	-1.10	-1.10
Cash from Financing Activities	--	5.01	11.75	28.88	24.99	29.05
Net Cash Inflow / Outflow	--	--	--	-1.54	7.28	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-7.25	-10.62	-31.77	-30.99	-18.44	--
Cash EPS ($)	--	-10.38	-31.38	-30.88	-18.44	--
Adjusted Book Value ($)	--	4.78	22.88	38.74	37.34	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-8.02	-27.34	-29.56	-16.62	--
Free Cash Flow per Share ($)	--	-8.07	-28.89	-30.43	-17.72	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-129.72	-102.80	-81.46	-56.75	-63.72
ROE (%)	-438.82	-130.94	-103.12	-81.46	-56.75	-63.72
ROA (%)	-136.96	-117.54	-98.03	-78.09	-54.36	-59.37
EBIT Margin (%)	-853.97	-2,894.68	--	-35,271,257.95	--	--
Net Margin (%)	-1,040.11	-2,894.68	--	-4,447.10	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	210.11	--	-1.00	--	--	--
EBIT Growth (%)	36.25	33.19	-2.44	-66.04	-55.94	-207.52
Net Profit Growth (%)	21.86	33.13	-2.53	-68.04	-56.90	-205.89
EPS Growth (%)	66.25	0.67	-0.03	-0.68	--	--
Book Value Growth (%)	-88.54	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.66	-0.03	-0.29	-0.78	--
Price / Book Value	0.09	1.47	0.05	0.23	0.38	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.50	-0.42	0.49	0.81	1.12	2.34
Close Price ($)	2.01	7.02	26.25	221.75	358.00	133.75
High Price ($)	11.00	28.25	234.75	528.50	475.00	138.75
Low Price ($)	1.35	5.15	20.25	159.63	86.00	113.00
Market Cap ($ Cr)	0.29	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.01	0.01	--	--	--
Short term debt to equity ratio	0.03	0.01	0.01	--	--	--
Current Ratio	0.89	3.13	16.83	19.81	28.41	71.08
Quick Ratio	0.89	--	--	--	--	--
Interest Coverage	-116.04	--	-1,190.85	-41.50	--	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	59.12	--	2,949,260.23	--	--
Asset Turnover	0.13	0.04	--	0.00	--	--
Receivable days	--	154.38	--	10,772,172.98	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	682.57	1,135.32	4,574.21	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.